RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/24018270http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/24018270http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/24018270http://www.w3.org/2000/01/rdf-schema#comment"Killer Ig-like receptors (KIRs) are innate immune receptors expressed by NK and T cells classically associated with the detection of missing self through loss of their respective MHC ligand. Some KIR specificities for allelic classical class I MHC (MHC-I) have been described, whereas other KIR receptor-ligand relationships, including those associated with nonclassical MHC-I, have yet to be clearly defined. We report in this article that KIR3DL2 and KIR2DS4 and the nonclassical Ag HLA-F, expressed as a free form devoid of peptide, physically and functionally interact. These interactions extend to include classical MHC-I open conformers as ligands, defining new relationships between KIR receptors and MHC-I. The data collectively suggest a broader, previously unrecognized interaction between MHC-I open conformers--including prototypical HLA-F--and KIR receptors, acting in an immunoregulatory capacity centered on the inflammatory response."xsd:string
http://purl.uniprot.org/citations/24018270http://purl.org/dc/terms/identifier"doi:10.4049/jimmunol.1300081"xsd:string
http://purl.uniprot.org/citations/24018270http://purl.org/dc/terms/identifier"doi:10.4049/jimmunol.1300081"xsd:string
http://purl.uniprot.org/citations/24018270http://purl.uniprot.org/core/author"Lee N."xsd:string
http://purl.uniprot.org/citations/24018270http://purl.uniprot.org/core/author"Lee N."xsd:string
http://purl.uniprot.org/citations/24018270http://purl.uniprot.org/core/author"Geraghty D.E."xsd:string
http://purl.uniprot.org/citations/24018270http://purl.uniprot.org/core/author"Geraghty D.E."xsd:string
http://purl.uniprot.org/citations/24018270http://purl.uniprot.org/core/author"Burian A."xsd:string
http://purl.uniprot.org/citations/24018270http://purl.uniprot.org/core/author"Burian A."xsd:string
http://purl.uniprot.org/citations/24018270http://purl.uniprot.org/core/author"Goodridge J.P."xsd:string
http://purl.uniprot.org/citations/24018270http://purl.uniprot.org/core/author"Goodridge J.P."xsd:string
http://purl.uniprot.org/citations/24018270http://purl.uniprot.org/core/date"2013"xsd:gYear
http://purl.uniprot.org/citations/24018270http://purl.uniprot.org/core/date"2013"xsd:gYear
http://purl.uniprot.org/citations/24018270http://purl.uniprot.org/core/name"J. Immunol."xsd:string
http://purl.uniprot.org/citations/24018270http://purl.uniprot.org/core/name"J. Immunol."xsd:string
http://purl.uniprot.org/citations/24018270http://purl.uniprot.org/core/pages"3553-3562"xsd:string
http://purl.uniprot.org/citations/24018270http://purl.uniprot.org/core/pages"3553-3562"xsd:string
http://purl.uniprot.org/citations/24018270http://purl.uniprot.org/core/title"HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors."xsd:string
http://purl.uniprot.org/citations/24018270http://purl.uniprot.org/core/title"HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors."xsd:string
http://purl.uniprot.org/citations/24018270http://purl.uniprot.org/core/volume"191"xsd:string
http://purl.uniprot.org/citations/24018270http://purl.uniprot.org/core/volume"191"xsd:string
http://purl.uniprot.org/citations/24018270http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/24018270
http://purl.uniprot.org/citations/24018270http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/24018270